Stocks AMBIQ Financial statements
Financial statementsAmbipar Emergency Response financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Ambipar Emergency Response files with the SEC in its annual reports.
In BRL millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | |
|---|---|---|---|---|---|
| Revenue | 364 | 822 | 1,685 | 2,590 | 3,248 |
| Cost of revenue | 256 | 619 | 1,338 | 2,090 | 2,770 |
| Gross profit | 108 | 204 | 347 | 499 | 479 |
| Selling, general and administrative | 19 | 26.8 | 26.6 | 28.4 | 32.3 |
| Operating income | 89.9 | 178 | 337 | 360 | 486 |
| Interest expense | 14.5 | 12.8 | 114 | 295 | 593 |
| Interest income | 7.41 | 10.8 | 9.57 | 43.5 | 234 |
| Pre-tax income | 82.8 | 176 | 233 | 109 | 127 |
| Income tax | 16.8 | -37.9 | -44.9 | -91.9 | -68 |
| Net income to minority interests | 7.03 | 26.4 | 79.7 | 79.3 | |
| Net income | 61.7 | 131 | 161 | -62.5 | -20.6 |
| EBITDA | 112 | 238 | 449 | 542 | 808 |
| EPS, basic | 1.79 | 2.84 | 0.72 | 0.19 | 1.06 |
| EPS, diluted | 1.79 | 2.84 | 0.72 | 0.17 | 0.82 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | |
|---|---|---|---|---|---|
| Cash and equivalents | 61.8 | 119 | 272 | 423 | 358 |
| Receivables | 234 | 703 | 804 | 1,100 | |
| Inventory | 8.78 | 18.1 | 34.2 | 46.3 | |
| Total current assets | 453 | 1,133 | 1,440 | 1,750 | |
| Property, plant and equipment | 296 | 516 | 788 | 979 | |
| Lease right-of-use assets | 10.1 | 35.2 | 68.3 | 88.7 | 347 |
| Goodwill | 586 | 1,192 | 1,537 | 1,804 | |
| Intangible assets | 9.63 | 420 | 359 | 440 | |
| Total assets | 1,431 | 3,431 | 4,309 | 5,800 | |
| Accounts payable | 39.6 | 147 | 185 | 218 | |
| Total current liabilities | 346 | 717 | 803 | 978 | |
| Lease liabilities | 22 | 32.6 | 34.9 | 240 | |
| Total liabilities | 1,093 | 2,984 | 2,952 | 3,984 | |
| Total debt | 187 | 1,318 | 1,248 | 1,454 | |
| Retained earnings | 176 | 0 | -62.5 | -83 | |
| Shareholders' equity | 326 | 365 | 1,073 | 1,450 | |
| Minority interests | 11.9 | 81.7 | 284 | 367 | |
| Total equity | 327 | 338 | 447 | 1,357 | 1,816 |
| Total liabilities and equity | 1,431 | 3,431 | 4,309 | 5,800 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | |
|---|---|---|---|---|---|
| Net income | 66.1 | 138 | 188 | 17.2 | 58.8 |
| Depreciation and amortization | 22.5 | 60.2 | 112 | 182 | 323 |
| Cash from operations | 32.5 | 64.3 | 471 | 78.5 | 421 |
| Cash from investing | -118 | -448 | -1,321 | -287 | -135 |
| Debt issued | 22.4 | 50.6 | 447 | 124 | 154 |
| Debt repaid | -23.5 | -52.2 | -64 | -180 | -305 |
| Dividends paid | -0.06 | 0 | -31.9 | -51.7 | |
| Cash from financing | 109 | 433 | 995 | 417 | -514 |
| Exchange rate effect | 25.8 | 8.01 | 7.8 | -56.7 | 163 |
| Income taxes paid | 2.66 | 2.19 | 18.2 | 37 | 47.8 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 14.7% | Gross profit / revenue. |
| Operating margin | 15.0% | Operating income / revenue. |
| EBITDA margin | 24.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 3.9% | Pre-tax income / revenue. |
| Net margin | -0.6% | Net income / revenue. |
| Operating cash flow margin | 13.0% | Cash from operations / revenue. |
| Effective tax rate | -53.7% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | -1.6% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -0.4% | Net income / average total assets. |
| Return on invested capital (ROIC) | 17.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 1.0% | Selling, general and administrative expense / revenue. |
| D&A / revenue | 9.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 25.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 58.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -4.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 33.0% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 34.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 39.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 49.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 50.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 393.6% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -33.9% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 436.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 87.1% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 35.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 64.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 34.6% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 59.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.79x | Current assets / current liabilities. |
| Quick ratio | 1.49x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.37x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 1.00x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 25.1% | Total debt / total assets. |
| Liabilities / assets | 68.7% | Total liabilities / total assets. |
| Net debt | R$1.10B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.36x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 0.82x | Operating income / interest expense. |
| Working capital | R$771.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 38.7% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -R$793.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.64x | Revenue / average total assets. |
| Fixed asset turnover | 3.68x | Revenue / average property, plant and equipment. |
| Inventory turnover | 68.8x | Cost of revenue / average inventory. |
| Days inventory | 5 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 3.41x | Revenue / average receivables. |
| Days sales outstanding | 107 days | 365 x average receivables / revenue. |
| Days payables | 27 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 86 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | R$0.82 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | R$1.06 | Net income per basic share, as reported (split-adjusted). |
What was Ambipar Emergency Response's revenue in fiscal 2024?
Ambipar Emergency Response reported revenue of R$3.25B for fiscal 2024, 25.4% higher than the year before.
Was Ambipar Emergency Response profitable in fiscal 2024?
No. It reported a net loss of R$20.6M.